SEC Form 4 · accession 0001213900-18-007754
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve O'Loughlin
Officer — Principal Financial Officer
Period of report
Jun 15, 2018
Accepted (ET)
Jun 15, 2018 · 6:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2018 | P | 12,000 | $0.50 | A | 25,500 | D |
Table II — derivative securities
No Table II lines on this filing.